TTC3 and early-onset autosomal dominant Alzheimer disease: Taken together, this early upregulation of TTC3 may contribute to known metabolic dysfunction through promotion of mitochondrial stress and downregulation of key homeostatic processes and later protein aggregation associated with Alzheimer’s disease development in individuals with T21 (Lanzillotta and Di Domenico, 2021).